植入性鞘内镇痛泵钛过敏的诊断与管理:一例病例报告
本病例报告描述一名有腰椎手术史和难治性下背痛的患者,因怀疑感染两次取出鞘内泵,最终诊断为IV型钛过敏。通过用膨体聚四氟乙烯(ePTFE)织物包裹泵体,成功重新植入鞘内药物输注系统且未发生排斥。结论提示对反复或不明原因泵部位并发症的患者应考虑装置组分过敏。
要点
- 反复泵部位并发症应警惕装置组分过敏而非感染。
- IV型钛过敏患者可用ePTFE包裹泵体后重新植入。
- ePTFE包裹或使过敏患者再次植入神经调控装置成为可能。
核心结论
- 对装置组分的过敏反应应纳入反复或不明原因泵部位并发症的鉴别诊断。
- 使用ePTFE包裹可能使对植入性神经调控装置存在IV型超敏反应的患者得以重新植入装置。
研究设计与样本
- 病例报告:一名有腰椎手术史和难治性下背痛的患者,因怀疑感染两次取出鞘内泵。
- 最终诊断为IV型钛超敏反应,并采用ePTFE织物包裹泵体后成功重新植入鞘内药物输注系统。
主要发现
- 患者因怀疑感染经历两次鞘内泵取出。
- 最终诊断为IV型钛超敏反应。
- 以ePTFE包裹泵体后重新植入鞘内药物输注系统,未发生排斥。
临床怎么用
- 对反复或不明原因泵部位并发症的患者,应考虑装置组分超敏反应的可能。
- 对植入性神经调控装置存在IV型超敏反应的患者,可考虑用ePTFE包裹装置后重新植入。
局限性
- 为单例病例报告,结论的外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypersensitivity reactions to implanted neuromodulation devices often mimic infection and result in device explants. Among device components, titanium is an infrequent immune irritant that can lead to implant rejection. CASE PRESENTATION: This case report describes a patient with a history of prior lumbar spine surgery and refractory low back pain who had two intrathecal pump explants for suspicion of infection and who was ultimately diagnosed to have a type IV titanium hypersensitivity. An intrathecal drug delivery system was successfully reimplanted without rejection by encasing the pump with a pouch of expanded polytetrafluoroethylene (ePTFE) fabric. CONCLUSIONS: Hypersensitivity to device components should be considered in patients with recurrent or unexplained pump site complications. The use of an ePTFE pouch may allow device reimplantation in patients with type IV hypersensitivity reactions to implanted neuromodulation devices.
引用
- Kiernan J, Al Salak C, Tcheurekdjian H, et al. Diagnosis and management of hypersensitivity to titanium in implanted intrathecal pain pump: a case report. Reg Anesth Pain Med. 2026. PMID: 42710952. doi:10.1136/rapm-2026-108132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。